China Resources Medical Holdings Company Limited (1515.HK)
Beijing, CN
Operating as an investment holding firm, China Resources Medical Holdings Company Limited delivers a spectrum of healthcare services, encompassing general medical care, hospital administration, and advisory functions within the People's Republic of China. Its business activities are structured into three main divisions: hospitals it directly owns, facilities managed under Invest-Operate-Transfer (IOT) or Operate-Transfer (OT) agreements, and other ancillary operations. The company further provides group purchasing solutions and various services derived from its hospital network. A key component of its strategy involves managing and operating external hospitals and clinics through its IOT model. Additionally, the enterprise is active in the sale of pharmaceuticals, medical apparatus, medical consumables, and specialized equipment. Established in 2007, the company adopted its current name, China Resources Medical Holdings Company Limited, in October 2018, having previously been known as China Resources Phoenix Healthcare Holdings Company Limited. Its corporate headquarters are located in Beijing, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.39% | +1.98% | -9.82% | -16.29% | -21.65% | -19.94% | -37.62% | -59.08% | -68.92% | -76.29% | -74.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-6.9% Q4'25: -6.9% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%-13.3% Q4'25: +218.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+4.2% Q4'25: +13.3% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+4.6% Q4'25: +4.1% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+4.1% Q4'25: +7.5% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.90× ★ Q4'25: 0.47× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
887.35M
est: 800.90M (+10.8%)
|
1.21B
est: 878.30M (+37.3%)
|
1.37B
est: 1.63B (-16.0%)
|
1.53B
est: 1.80B (-14.7%)
|
1.88B
est: 2.27B (-17.2%)
|
2.06B
est: 2.30B (-10.4%)
|
2.12B
est: 2.02B (+4.7%)
|
2.75B
est: 2.79B (-1.4%)
|
4.45B
est: 4.23B (+5.1%)
|
7.90B
est: 6.54B (+20.8%)
|
10.11B
est: 9.27B (+9.0%)
|
9.85B
est: 10.52B (-6.3%)
|
9.18B
est: 9.00B (+2.0%)
|
9.72B
9.63B – 9.81B
+8.1% YoY
|
9.96B
9.77B – 10.15B
+2.4% YoY
|
10.28B
10.13B – 10.43B
+3.2% YoY
|
| EBITDA |
171.60M
est: 100.91M (+70.1%)
|
247.91M
est: 115.74M (+114.2%)
|
220.92M
est: 365.52M (-39.6%)
|
-1.40B
est: 269.74M (-619.4%)
|
519.92M
est: -1.37B (+137.9%)
|
602.86M
est: 570.36M (+5.7%)
|
572.37M
est: 547.26M (+4.6%)
|
372.58M
est: 492.58M (-24.4%)
|
527.91M
est: 513.34M (+2.8%)
|
965.25M
est: 647.07M (+49.2%)
|
1.22B
est: 1.11B (+9.9%)
|
1.31B
est: 1.04B (+26.2%)
|
946.57M
est: 1.08B (-12.0%)
|
1.16B
1.15B – 1.17B
+8.1% YoY
|
1.19B
1.17B – 1.21B
+2.4% YoY
|
1.23B
1.21B – 1.25B
+3.2% YoY
|
| EBIT |
138.56M
est: 61.01M (+127.1%)
|
212.12M
est: 155.07M (+36.8%)
|
179.66M
est: 340.18M (-47.2%)
|
234.57M
est: 296.70M (-20.9%)
|
456.57M
est: -1.35B (+133.9%)
|
533.25M
est: 487.06M (+9.5%)
|
508.72M
est: 505.28M (+0.7%)
|
278.11M
est: 469.34M (-40.7%)
|
367.68M
est: 489.11M (-24.8%)
|
478.84M
est: 616.53M (-22.3%)
|
607.78M
est: 604.35M (+0.6%)
|
752.69M
est: 831.20M (-9.4%)
|
422.51M
est: 586.28M (-27.9%)
|
633.71M
627.81M – 639.60M
+8.1% YoY
|
649.09M
636.79M – 661.38M
+2.4% YoY
|
669.94M
660.43M – 679.45M
+3.2% YoY
|
| Net Income |
89.99M
est: 156.14M (-42.4%)
|
230.05M
est: 77.28M (+197.7%)
|
167.05M
est: 245.78M (-32.0%)
|
-1.51B
est: 176.92M (-951.8%)
|
421.03M
est: -1.45B (+129.0%)
|
430.90M
est: 379.06M (+13.7%)
|
390.87M
est: 365.98M (+6.8%)
|
310.13M
est: 330.03M (-6.0%)
|
417.92M
est: 343.94M (+21.5%)
|
265.86M
est: 291.98M (-8.9%)
|
257.68M
est: 273.43M (-5.8%)
|
565.88M
est: 606.63M (-6.7%)
|
495.94M
est: 518.14M (-4.3%)
|
474.63M
465.87M – 483.39M
-8.4% YoY
|
489.14M
480.11M – 498.17M
+3.1% YoY
|
493.00M
483.90M – 502.10M
+0.8% YoY
|
| SGA |
74.13M
est: 86.54M (-14.3%)
|
85.59M
est: 63.62M (+34.5%)
|
149.92M
est: 91.44M (+64.0%)
|
172.06M
est: 158.78M (+8.4%)
|
211.66M
est: 165.52M (+27.9%)
|
223.43M
est: 190.56M (+17.2%)
|
253.57M
est: 189.82M (+33.6%)
|
337.97M
est: 215.43M (+56.9%)
|
488.23M
est: 224.51M (+117.5%)
|
828.19M
est: 283.00M (+192.6%)
|
973.50M
est: 979.98M (-0.7%)
|
1.05B
est: 1.11B (-5.5%)
|
1.02B
est: 950.68M (+7.1%)
|
1.03B
1.02B – 1.04B
+8.1% YoY
|
1.05B
1.03B – 1.07B
+2.4% YoY
|
1.09B
1.07B – 1.10B
+3.2% YoY
|
| EPS |
0.16
est: 0.12 (+29.6%)
|
0.28
est: 0.19 (+45.2%)
|
0.20
est: 0.32 (-37.2%)
|
-1.67
est: 0.03 (-4,948.9%)
|
0.33
est: 0.39 (-16.2%)
|
0.34
est: 0.37 (-7.4%)
|
0.31
est: 0.34 (-7.6%)
|
0.25
est: 0.35 (-27.6%)
|
0.33
est: 0.38 (-13.3%)
|
0.21
est: 0.13 (+63.1%)
|
0.20
est: 0.22 (-7.5%)
|
0.45
est: 0.48 (-6.2%)
|
0.39
est: 0.41 (-4.8%)
|
0.38
0.37 – 0.38
-8.4% YoY
|
0.39
0.38 – 0.39
+3.1% YoY
|
0.39
0.38 – 0.40
+0.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-28 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-27 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-26 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 4/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 1/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-15 | B+ | 3/5 | 1/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 211.4K | 0.65% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.03% | 496.5K | 0.58% |
| 3 | Avantis Emerging Markets Value ETF AVES | 0.02% | 305.0K | 0.36% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.02% | 6.6K | 0.54% |
| 5 | State Street SPDR S&P China ETF GXC | 0.01% | 54.9K | 0.59% |
| 6 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 29.4K | 0.35% |
| 7 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 13.6K | 0.42% |
| 8 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.00M | 0.06% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.01% | 1.40M | 0.33% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 473.5K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hai Yu | Chairman | 3M | male |
| Chuang Zhang | Chief Executive Officer & Executive Director | 231.1K | male |
| Xinchun Wu | Executive Director & Vice President | 214.9K | male |
| Dayi Gong | Vice President | — | male |
| Bing Zhang | Vice President | — | male |
| Ming Fai Chung | Company Secretary | — | male |
| Yuexing Wang | Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1515.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
